Minocycline and Other Tetracycline Derivatives: A Neuroprotective Strategy in Parkinson’s Disease and Huntington’s Disease

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain

DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J., & D, N. A. M. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,849 · see citing works

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,071 · see citing works

Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease

Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,068 · see citing works

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,056 · see citing works

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · see citing works

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040 · see citing works

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia

Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · see citing works

Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients

Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · see citing works

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease

Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789 · see citing works

Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization

Lassus, P., Opitz-Araya, X., & Lazebnik, Y. A. (2002) · Science · doi:10.1126/science.1074721 · Cited by 719 · see citing works

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease

Hartmann, A., Hunot, S., Michel, P. P., Muriel, M., Vyas, S., Faucheux, B. A., Prigent, A., Turmel, H., Srinivasan, A. N., Ruberg, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556597 · Cited by 717 · see citing works

Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease

Dunah, A. W., Jeong, H., Griffin, A. M., Kim, Y., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708 · see citing works

Outcomes of total hip and knee replacement: Preoperative functional status predicts outcomes at six months after surgery

Fortin, P. R., Clarke, A. E., Joseph, L., Liang, M. H., Tänzer, M., Ferland, D., Phillips, C., Partridge, A. J., B�lisle, P., Fossel, A. H., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8 · Cited by 708 · see citing works

Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

Ona, V. O., Li, M., Vonsattel, J. P., Andrews, L. J., Khan, S. Q., Chung, W. M., Frey, A. S., Menon, A., Li, X., Stieg, P. E., et al. (1999) · Nature · doi:10.1038/20446 · Cited by 640 · see citing works

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, É. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 591 · see citing works

Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

Goldberg, Y. P., Nicholson, D. W., Rasper, D., Kalchman, M. A., Koide, H., Graham, R. K., Bromm, M., Kazemi‐Esfarjani, P., Thornberry, N. A., Vaillancourt, J. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-442 · Cited by 584 · see citing works

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547 · see citing works

Minocycline Provides Neuroprotection Against N -Methyl- d -aspartate Neurotoxicity by Inhibiting Microglia

Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 530 · see citing works

Failure of the ubiquitin-proteasome system in Parkinson’s disease

McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519 · see citing works

MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia

Alessandrini, A., Namura, S., Moskowitz, M. A., & Bonventre, J. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12866 · Cited by 464 · see citing works

Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release

Jana, N. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1049 · Cited by 453 · see citing works

Histochemical detection of apoptosis in Parkinson's disease

Mochizuki, H., Goto, K., Mori, H., & Mizuno, Y. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00336-z · Cited by 452 · see citing works

Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration

Liu, B., Gao, H., Wang, J., Jeohn, G., Cooper, C. L., & Hong, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04077.x · Cited by 425 · see citing works

Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease

Tatton, N. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7489 · Cited by 411 · see citing works

Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction

Sanchez-Mejia, R., Ona, V., Li, M.-W., & Friedlander, R. (2001) · Neurosurgery · doi:10.1097/00006123-200106000-00051 · Cited by 373 · see citing works

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

He, Y., Appel, S. H., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 350 · see citing works

Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage through Inhibition of Microglia Activation and Superoxide Generation

Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · cited 1× · see citing works

Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury

Arvin, K. L., Han, B., Du, Y.-S., Lin, S.-Z., Paul, S. M., & Holtzman, D. (2002) · Annals of Neurology · doi:10.1002/ana.10242 · Cited by 323 · see citing works

Minocycline delays disease onset and mortality in a transgenic model of ALS

Bosch, L. V. D., Tilkin, P., Lemmens, G., & Robberecht, W. (2002) · Neuroreport · doi:10.1097/00001756-200206120-00018 · Cited by 297 · see citing works

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Kohutnicka, M., Lewandowska, E., Kurkowska‐Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283 · see citing works

Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain

Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 283 · see citing works

Microglial Reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Induced Parkinson's Disease Mice Model

Członkowska, A., Kohutnicka, M., Kurkowska‐Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279 · see citing works

The Transcription Factor NF‐κB Mediates Increases in Calcium Currents and Decreases in NMDA‐ and AMPA/Kainate‐Induced Currents Induced by Tumor Necrosis Factor‐α in Hippocampal Neurons

Furukawa, K., & Mattson, M. P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051876.x · Cited by 254 · see citing works

Recent advances in the genetics and pathogenesis of Parkinson disease

Mouradian, M. M. (2002) · Neurology · doi:10.1212/wnl.58.2.179 · Cited by 227 · see citing works

Safety of long-term high-dose minocycline in the treatment of acne

Goulden, V., GLASS, D., & Cunliffe, W. J. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb06972.x · Cited by 218 · see citing works

Minocycline-induced autoimmune syndromes: An overview

Elkayam, O., Yaron, M., & Caspi, D. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80004-3 · Cited by 173 · see citing works

Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction

Mejia, R. O. S., Ona, V. O., Li, M., et al. (2001) · Neurosurgery · doi:10.1227/00006123-200106000-00051 · Cited by 171 · see citing works

Microglial response to 6-hydroxydopamine-induced substantia nigra lesions

Akiyama, H., & McGeer, P. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)90857-3 · Cited by 169 · see citing works

Cell death mechanisms in neurodegeneration

Jellinger, K. A. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00134.x · Cited by 166 · see citing works

CEP‐1347/KT‐7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ‐induced cortical neuron apoptosis

Bozyczko‐Coyne, D., O’Kane, T. M., Wu, Z.-L., Dobrzański, P., Murthy, S., Vaught, J. L., & Scott, R. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00294.x · Cited by 151 · see citing works

Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease

Tikka, T., Vartiainen, N. E., Goldsteins, G., Oja, S. S., Andersen, P. M., Marklund, S. L., & Koıstınaho, J. (2002) · Brain · doi:10.1093/brain/awf068 · Cited by 136 · see citing works

Inflammation, Apoptosis, and Alzheimer's Disease

Bamberger, M. E., & Landreth, G. E. (2002) · The Neuroscientist · doi:10.1177/1073858402008003013 · Cited by 127 · see citing works

Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons

Lin, S., Zhang, Y., Dodel, R. C., Farlow, M. R., Paul, S. M., & Du, Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02324-2 · Cited by 126 · see citing works

Post‐transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines

Amin, A. R., Patel, R. N., Thakker, G. D., Lowenstein, C. J., Attur, M. G., & Abramson, S. B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00605-4 · Cited by 119 · see citing works

Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation

Tikka, T., Usenius, T., Tenhunen, M., Keinänen, R., & Koistinaho, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00543.x · Cited by 96 · see citing works

6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra

He, Y., Lee, T., & Leong, S. K. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02459-2 · Cited by 90 · see citing works

Potential of tetracyclines to modify cartilage breakdown in osteoarthritis

RYAN, M. E., Greenwald, R. A., & Golub, L. M. (1996) · Current Opinion in Rheumatology · doi:10.1097/00002281-199605000-00013 · Cited by 86 · see citing works

A Chemically Modified Nonantimicrobial Tetracycline (CMT‐8) Inhibits Gingival Matrix Metalloproteinases, Periodontal Breakdown, and Extra‐Oral Bone Loss in Ovariectomized Rats

Golub, L. M., RAMAMURTHY, N. S., Llavaneras, A., RYAN, M. E., Lee, H. M., Liu, Y., Bain, S. C., & Sorsa, T. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07691.x · Cited by 81 · see citing works

Mechanisms of Neurodegenerative Disorders

Wolozin, B. L., & Behl, C. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.793 · Cited by 70 · see citing works

Minocycline related lupus.

Masson, C., Chevailler, A., Pascaretti, C., Legrand, É., Brégeon, C., & Audran, M. (1996) · PubMed · Cited by 43 · see citing works

Mechanisms of Neurodegenerative Disorders

Wolozin, B. L., & Behl, C. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.801 · Cited by 40 · see citing works

Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis

Volbracht, C., Fava, E., Leist, M., & Nicotera, P. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00008 · Cited by 39 · see citing works

Role of Caspase 1 in Neurologic Disease

Friedlander, R. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.9.1273 · Cited by 34 · see citing works

Minocycline induced lupus and autoimmune hepatitis.

Angulo, J. M., Sigal, L. H., & Espinoza, L. R. (1999) · PubMed · Cited by 28 · see citing works

Protective Effect of a Prosaposin-Derived, 18-Mer Peptide on Slowly Progressive Neuronal Degeneration after Brief Ischemia

Morita, F., Wen, T., Tanaka, J., Hata, R., Desaki, J., Sato, K., Nakata, K., Ma, Y.-J., & Sakanaka, M. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200111000-00005 · Cited by 27 · see citing works

Minocycline and Pseudotumor cerebri: The Well-Known but Well-Kept Secret

Weese‐Mayer, D. E., Yang, R. J., Mayer, J. R., & Zaparackas, Z. (2001) · PEDIATRICS · doi:10.1542/peds.108.2.519 · Cited by 24 · see citing works

Minocycline-induced lupus-like syndrome

Balestrero, S., Ciambellotti, A., Parodi, A., & Rebora, A. (2001) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2001.01173-3.x · Cited by 12 · see citing works

Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies

Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3 · see citing works

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1 · see citing works

Inflammation and the Degenerative Diseases of Aging

McGeer, P. L., & McGeer, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 519 · see citing works

Novel anti-inflammatory therapy for Parkinson's disease

Gao, H., Liu, B., Zhang, W., & Hong, J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00176-7 · Cited by 324 · see citing works

Minocycline as a Neuroprotective Agent

Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., & Tetzlaff, W. (2005) · The Neuroscientist · doi:10.1177/1073858405275175 · Cited by 280 · see citing works

Pharmacological Approaches To Repair the Injured Spinal Cord

Baptiste, D. C., & Fehlings, M. G. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.318 · Cited by 268 · see citing works

Neuroprotective agents for clinical trials in Parkinson’s disease

Ravina, B. M., Fagan, S. C., Hart, R. G., Hovinga, C. A., Murphy, D. D., Dawson, T. M., & Marler, J. R. (2003) · Neurology · doi:10.1212/01.wnl.0000058760.13152.1a · Cited by 261 · see citing works

Deleterious Effects of Minocycline in Animal Models of Parkinson’s Disease and Huntington’s Disease

Diguet, E., Fernagut, P., Wei, X., Du, Y., Rouland, R., Gross, C., Bezard, E., & Tison, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03372.x · Cited by 189 · see citing works

Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis

Mishra, M. K., & Basu, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05238.x · Cited by 167 · see citing works

Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets

Potts, M. B., Koh, S.-E., Whetstone, W. D., Walker, B. A., Yoneyama, T., Claus, C. P., Manvelyan, H. M., & Noble-Haeusslein, L. J. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.006 · Cited by 164 · see citing works

Minocycline Confers Early but Transient Protection in the Immature Brain following Focal Cerebral Ischemia—Reperfusion

Fox, C. K., Dingman, A., Derugin, N., Wendland, M. F., Manabat, C., Ji, S., Ferriero, D. M., & Vexler, Z. S. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600121 · Cited by 157 · see citing works

Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study

Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181593d45 · Cited by 146 · see citing works

Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures

Abraham, J., Fox, P. D., Condello, C., Bartolini, A., & Koh, S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.02.006 · Cited by 140 · see citing works

Classification Framework and Chemical Biology of Tetracycline-Structure-Based Drugs

Fuoco, D. (2012) · Antibiotics · doi:10.3390/antibiotics1010001 · Cited by 141 · see citing works

Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers

Diomede, L., Cassata, G., Fiordaliso, F., Salio, M., Ami, D., Natalello, A., Doglia, S. M., Luigi, A. D., & Salmona, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.002 · Cited by 114 · see citing works

Inhibition of thrombin‐induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo

Choi, S. H., Lee, D. Y., Chung, E. S., Hong, Y. B., Kim, S. U., & Jin, B. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03503.x · Cited by 111 · see citing works

Minocycline in Huntington's disease: A pilot study

Thomas, M., Ashizawa, T., & Jankovic, J. J. (2004) · Movement Disorders · doi:10.1002/mds.20018 · Cited by 111 · see citing works

Reactive Oxygen Species and Inhibitors of Inflammatory Enzymes, NADPH Oxidase, and iNOS in Experimental Models of Parkinson’s Disease

Koppula, S., Kumar, H., Kim, I. S., & Choi, D. (2012) · Mediators of Inflammation · doi:10.1155/2012/823902 · Cited by 107 · see citing works

Possible antipsychotic effects of minocycline in patients with schizophrenia

Miyaoka, T., Yasukawa, R., YASUDA, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.013 · Cited by 105 · see citing works

Rise and fall of minocycline in neuroprotection: need to promote publication of negative results

Diguet, E., Gross, C. E., Tison, F., & Bézard, E. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.016 · Cited by 97 · see citing works

The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works

Doxycycline Is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3

Cho, Y., Son, H. J., Kim, E.-M., Choi, J. H., Kim, S. T., Ji, I. J., Choi, D. H., Joh, T. H., Kim, Y. S., & Hwang, O. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9078-1 · Cited by 85 · see citing works

Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?

Waldmeier, P. C., & Tatton, W. G. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)03000-9 · Cited by 85 · see citing works

The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus–associated neurological disease: From mechanism to treatment

Clements, J. E., Mankowski, J. L., Gama, L., & Zink, M. C. (2008) · Journal of NeuroVirology · doi:10.1080/13550280802132832 · Cited by 81 · see citing works

Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer Disease

Costa, A. R., Speretta, E., Crowther, D. C., & Cardoso, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274548 · Cited by 79 · see citing works

Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy

Olanow, C. W., & Jankovic, J. J. (2005) · Movement Disorders · doi:10.1002/mds.20457 · Cited by 61 · see citing works

Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions

Fernández-Gómez, F.-J., Galindo, M. F., Gómez-Lázaro, M., González-García, C., Ceña, V., Aguirre, N., & Jordán, J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.019 · Cited by 59 · see citing works

Minocycline and intracerebral hemorrhage: influence of injury severity and delay to treatment

Szymanska, A., Biernaskie, J. A., Laidley, D. T., Granter‐Button, S., & Corbett, D. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.09.011 · Cited by 56 · see citing works

Doxycycline increases neurogenesis and reduces microglia in the adult hippocampus

Sultan, S., Gebara, E., & Toni, N. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00131 · Cited by 53 · see citing works

Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review

Dailah, H. G. (2022) · Molecules · doi:10.3390/molecules27217207 · Cited by 50 · see citing works

Minocycline delays disease onset and mortality in reovirus encephalitis

Richardson-Burns, S. M., & Tyler, K. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.015 · Cited by 49 · see citing works

The Role of Inflammation in Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis

Fołta, J., Rzepka, Z., & Wrześniok, D. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115177 · Cited by 47 · see citing works

Tetracycline: Classification, Structure Activity Relationship and Mechanism of Action as a Theranostic Agent for Infectious Lesions-A Mini Review

Rizvi, S. F. A. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.07.001475 · Cited by 40 · see citing works

Minocycline mitigates isoflurane-induced cognitive impairment in aged rats

Li, S.-Y., Xia, L., Zhao, Y., Liu, Y., Chen, Y.-L., Wang, J.-T., & Luo, A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.025 · Cited by 38 · see citing works

Neuroprotective agents for clinical trials in Parkinson’s disease: A systematic assessment

Diguet, E., Gross, C. E., Bézard, E., Tison, F., Stefanova, N., & Wenning, G. K. (2004) · Neurology · doi:10.1212/wnl.62.1.158 · Cited by 35 · see citing works

Minocycline Partially Inhibits Caspase-3 Activation and Photoreceptor Degeneration after Photic Injury

Chang, C.-J., Cherng, C., Liou, W., & Liao, C. (2005) · Ophthalmic Research · doi:10.1159/000086610 · Cited by 27 · see citing works

A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP

Son, H. J., Lee, J. A., Shin, N., Choi, J. H., Seo, J. W., Yoon, D., Lee, C.-S., Kim, E., Choe, H., & Hwang, O. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01692.x · Cited by 26 · see citing works

Monocyte Transmodulation: The Next Novel Therapeutic Approach in Overcoming Ischemic Stroke?

Park, J., Chang, J. Y., Kim, J. Y., & Lee, J. E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.578003 · Cited by 25 · see citing works

Changes of Blood–Brain Barrier Permeability Following Intracerebral Hemorrhage and the Therapeutic Effect of Minocycline in Rats

Shi, W., Wang, Z., Pu, J., Wang, R., Guo, Z., Liu, C., Sun, J., Gao, L., & Zhou, R. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0356-2_12 · Cited by 25 · see citing works

AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System

Marino, M., & Holt, M. G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.870799 · Cited by 24 · see citing works

The role of MAPK/NF-κB-associated microglial activation in T-2 toxin-induced mouse learning and memory impairment

Li, N., Yao, C., Diao, J., Liu, X., Tang, E., Huang, Q.-S., Zhou, Y., Hu, Y.-G., Li, X.-K., Long, J., et al. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113663 · Cited by 21 · see citing works

Minocycline-induced activation of tetracycline-responsive promoter

Chtarto, A., Tenenbaum, L., Velu, T. J., Brotchi, J., Levivier, M., & Blum, D. L. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.067 · Cited by 18 · see citing works

Traumatic injury to the immature brain: Inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets

Potts, M. B., Koh, S., Whetstone, W. D., Walker, B. A., Yoneyama, T., Claus, C. P., Manvelyan, H. M., & Noble‐Haeusslein, L. J. (2006) · Neurotherapeutics · doi:10.1007/bf03207045 · Cited by 17 · see citing works

Effects of Minocycline and Valproic Acid Coadministration on Atazanavir Plasma Concentrations in Human Immunodeficiency Virus-Infected Adults Receiving Atazanavir-Ritonavir

DiCenzo, R., Peterson, D. R., Cruttenden, K., Mariuz, P., Rezk, N. L., Hochreiter, J. S., Gelbard, H. A., & Schifitto, G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00194-08 · Cited by 16 · see citing works

Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a Caenorhabditis elegans Model of Tauopathy

Gamir-Morralla, A., Sacristán, S., Medina, M., & Iglesias, T. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180087 · Cited by 12 · see citing works

Why minocycline can cause systemic lupus – a hypothesis and suggestions for therapeutic interventions based on it

Steensel, M. A. M. V. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.040 · Cited by 13 · see citing works

Deteksi Aging pada Perempuan Berdasarkan Status Antioksidan

Winarsi, H., Yuniati, A., & Purwanto, A. J. (2013) · Majalah kedokteran Bandung/Majalah Kedokteran Bandung · doi:10.15395/mkb.v45n3.143 · Cited by 7 · see citing works

Scope and Limitations of Exploiting the Ability of the Chemosensitizer NV716 to Enhance the Activity of Tetracycline Derivatives against Pseudomonas aeruginosa

Draveny, M., Rose, C., Pinet, A., Ferrié, L., Figadère, B., Brunel, J. M., & Masi, M. (2023) · Molecules · doi:10.3390/molecules28114262 · Cited by 5 · see citing works

Brain chemotherapy from the bench to the clinic: targeting neuronal survival with small molecule inhibitors of apoptosis

Paul, C. C. (2005) · Frontiers in bioscience · doi:10.2741/1551 · Cited by 5 · see citing works

Huntington Disease

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5 · see citing works

Caspases; Modulators of Apoptosis and Cytokine Maturation — Targets for Novel Therapies

Knight, M. J., & Hawkins, C. J. (2006) · Springer eBooks · doi:10.1007/0-387-23695-3_4 · Cited by 4 · see citing works

Dopamine and Glutamate in Huntington’s Disease

Cepeda, C., Ariano, M. A., & Levine, M. S. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_23 · Cited by 2 · see citing works

Huntington disease

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00014-7 · Cited by 2 · see citing works

Exploring minocycline's effect on retinal degeneration following N-methyl-N-nitrosourea exposure in rats

Karabulut, B., Eröksüz, H., Eröksüz, Y., & Gul, M. (2025) · Veterinární Medicína · doi:10.17221/122/2024-vetmed · Cited by 1 · see citing works

Huntington disease

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1 · see citing works

Neuroprotection in Hungtington's Disease

Lahousen, T., & Bonelli, R. M. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200309000-00001 · Cited by 1 · see citing works

Neuroprotection in Hungtington's Disease: RESPONSE FROM THE AUTHORS

Thomas, M., Le, W. D., & Jankovic, J. J. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200309000-00002

Reply: Huntington's disease and minocycline

Thomas, M., Ashizawa, T., & Jankovic, J. J. (2005) · Movement Disorders · doi:10.1002/mds.20430

Psychotropic Activity of Selective Tetracyclines

Kishore, M., & Patil, P. (2011)

CASPASES; MODULATORS OF APOPTOSIS AND CYTOKINE MATURATION - TARGETS FOR NOVEL THERAPIES Chapter IV

Knight, M. J., & Hawkins, C. J. (2005)

Neuroprotective drug delivery to the injured spinal cord with hyaluronan and methylcellulose.

Kang, C. E. (2010) · TSpace (University of Toronto)

Relationship between central cholinergic system and neuroinflammation a molecular pharmacological approach

Tyagi, E. (2011) · Shodhganga

PARKINSON’S DISEASE (PD) / ATYPICAL PARKINSONIAN SYNDROMES. CLINICAL AND THERAPEUTIC CARACTHERISTICS

SUCIU, V., Caravia, L. G., Petrusca, I., POPOVICI, R., Pintilie, A., & DIACONESCU, S. (2025) · Romanian Journal of Medical Rehabilitation Physical Medicine and Balneoclimatology · doi:10.59277/rjmrpmb.2024.3.12

A REVIEW ARTICLE ON TREATING HUNTINGTON’S DISEASE: CURRENT AND EMERGING THERAPEUTIC ASPECTS

BARDE, N. A., Kore, P. S., & DD, B. (2025) · Innovare Journal of Medical Sciences · doi:10.22159/ijms.2025v13i1.53191

The Therapeutic Role of Minocycline in Parkinson’s Disease

Cankaya, S., Cankaya, B., Kilic, U., Kilic, E., & Yulug, B. (2019) · Drugs in Context · doi:10.7573/dic.212553 · Cited by 93 · see citing works

Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease

Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 105 · see citing works

Investigation of potential neuroprotective effects of non-antibiotic tetracycline derivatives in an animal model of Parkinson\'s disease

de Abreu, L. B. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Minocycline: Neuroprotective Mechanisms in Parkinsons Disease

Thomas, M., & Le, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453162 · Cited by 114 · see citing works

Revisiting safety of minocycline as neuroprotection in Huntington's disease

Reynolds, N. C. (2006) · Movement Disorders · doi:10.1002/mds.21199 · Cited by 22 · see citing works